Showing results (61-70 of 118) with videos related to

Sort By:
Pageof 12
Sexually Transmitted Infections|August 13, 2014
Verified clinical failure with cefotaxime 1g for treatment of gonorrhoea in the Netherlands: a case reportAlje P van Dam, Marc L van Ogtrop, Daniel Golparian, et al.
Frontiers in Microbiology|December 24, 2015
Genetic Resistance Determinants, In Vitro Time-Kill Curve Analysis and Pharmacodynamic Functions for the Novel Topoisomerase II Inhibitor ETX0914 (AZD0914) in Neisseria gonorrhoeaeSunniva Foerster, Daniel Golparian, Susanne Jacobsson, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|November 21, 2017
In vitro activity and time-kill curve analysis of sitafloxacin against a global panel of antimicrobial-resistant and multidrug-resistant Neisseria gonorrhoeae isolatesAgnez Jönsson, Sunniva Foerster, Daniel Golparian, et al.
Frontiers in Microbiology|January 31, 2022
First National Genomic Epidemiological Study of <i>Neisseria gonorrhoeae</i> Strains Spreading Across Sweden in 2016Ronza Hadad, Daniel Golparian, Inga Velicko, et al.
BMC Infectious Diseases|February 1, 2015
Antimicrobial susceptibility/resistance and NG-MAST characterisation of Neisseria gonorrhoeae in Belarus, Eastern Europe, 2010-2013Fiodar Lebedzeu, Daniel Golparian, Leonid Titov, et al.
The Journal of Antimicrobial Chemotherapy|March 2, 2019
Genome-based epidemiology and antimicrobial resistance determinants of Neisseria gonorrhoeae isolates with decreased susceptibility and resistance to extended-spectrum cephalosporins in Argentina in 2011-16Ricardo A Gianecini, Daniel Golparian, Sandra Zittermann, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|August 25, 2015
Evaluation of the new AmpliSens multiplex real-time PCR assay for simultaneous detection of Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium, and Trichomonas vaginalisTatiana Rumyantseva, Daniel Golparian, Christian S Nilsson, et al.
BMC Genomics|February 5, 2020
Genomic evolution of Neisseria gonorrhoeae since the preantibiotic era (1928-2013): antimicrobial use/misuse selects for resistance and drives evolutionDaniel Golparian, Simon R Harris, Leonor Sánchez-Busó, et al.
Frontiers in Pharmacology|June 7, 2021
Pharmacodynamic Evaluation of Dosing, Bacterial Kill, and Resistance Suppression for Zoliflodacin Against <i>Neisseria gonorrhoeae</i> in a Dynamic Hollow Fiber Infection ModelSusanne Jacobsson, Daniel Golparian, Joakim Oxelbark, et al.
Antimicrobial Agents and Chemotherapy|August 22, 2012
Genome sequencing of a Neisseria gonorrhoeae isolate of a successful international clone with decreased susceptibility and resistance to extended-spectrum cephalosporinsDavid Hess, Abel Wu, Daniel Golparian, et al.
Pageof 12